Works matching IS 00099236 AND DT 2019 AND VI 105 AND IP 2
Results: 39
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 277, doi. 10.1002/cpt.1327
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 284, doi. 10.1002/cpt.1326
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 282, doi. 10.1002/cpt.1325
- Publication type:
- Article
Generic Drugs: Expanding Possibilities for Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 278, doi. 10.1002/cpt.1320
- By:
- Publication type:
- Article
When Is a Medicine Good Enough?: Science, Similarity, and the History of Generic Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 290, doi. 10.1002/cpt.1316
- By:
- Publication type:
- Article
Generic Drugs in the United States: Policies to Address Pricing and Competition.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 329, doi. 10.1002/cpt.1314
- By:
- Publication type:
- Article
Batch‐to‐Batch and Within‐Subject Variability: What Do We Know and How Do These Variabilities Affect Clinical Pharmacology and Bioequivalence?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 326, doi. 10.1002/cpt.1294
- By:
- Publication type:
- Article
Evaluating Within‐Subject Variability for Narrow Therapeutic Index Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 411, doi. 10.1002/cpt.1293
- By:
- Publication type:
- Article
Impact of Pharmaceutical Excipients on Oral Drug Absorption: A Focus on Intestinal Drug Transporters.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 323, doi. 10.1002/cpt.1292
- By:
- Publication type:
- Article
On Bayesian Analysis and Hypothesis Testing in the Determination of Bioequivalence.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 304, doi. 10.1002/cpt.1291
- By:
- Publication type:
- Article
Bayesian Approach to Establish Bioequivalence: Why and How?
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 301, doi. 10.1002/cpt.1288
- By:
- Publication type:
- Article
Role of Authorized Generics in Postapproval Surveillance of Generic Drug Products.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 313, doi. 10.1002/cpt.1283
- By:
- Publication type:
- Article
Generating Model Integrated Evidence for Generic Drug Development and Assessment.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 338, doi. 10.1002/cpt.1282
- By:
- Publication type:
- Article
Opportunities and Challenges Related to the Implementation of Model‐Based Bioequivalence Criteria.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 350, doi. 10.1002/cpt.1270
- By:
- Publication type:
- Article
Lipid Lowering and Incidence of Cataract, a Role for Fibrates.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 318, doi. 10.1002/cpt.1269
- By:
- Publication type:
- Article
Suggestions for Streamlining and Optimizing Clinical End‐Point Bioequivalence Studies for US Abbreviated New Drug Application Submissions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 310, doi. 10.1002/cpt.1252
- By:
- Publication type:
- Article
Interchangeability of Generics—Experiences and Outlook Toward Pharmacokinetics Variability and Generic‐Generic Substitution.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 292, doi. 10.1002/cpt.1250
- By:
- Publication type:
- Article
Clinical Endpoint Bioequivalence Studies Are Needed: A Perspective From Brand Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 298, doi. 10.1002/cpt.1245
- By:
- Publication type:
- Article
Clinical Endpoint Bioequivalence Studies Are Not Sensitive: A Perspective From Generic Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 295, doi. 10.1002/cpt.1244
- By:
- Publication type:
- Article
Maximizing the Role of Physiologically Based Oral Absorption Modeling in Generic Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 307, doi. 10.1002/cpt.1242
- By:
- Publication type:
- Article
Pharmacokinetics‐Pharmacodynamics of High‐Dose Ivermectin with Dihydroartemisinin‐Piperaquine on Mosquitocidal Activity and QT‐Prolongation (IVERMAL).
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 388, doi. 10.1002/cpt.1219
- By:
- Publication type:
- Article
Clinical Evaluation of MK‐2640: An Insulin Analog With Glucose‐Responsive Properties.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 417, doi. 10.1002/cpt.1215
- By:
- Publication type:
- Article
Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy: Progress Continues.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 315, doi. 10.1002/cpt.1209
- By:
- Publication type:
- Article
A PK/PD Analysis of Circulating Biomarkers and Their Relationship to Tumor Response in Atezolizumab‐Treated non‐small Cell Lung Cancer Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 486, doi. 10.1002/cpt.1198
- By:
- Publication type:
- Article
Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Response to "Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?".
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Adverse Events Associated With PCSK9 Inhibitors: A Real‐World Experience.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 496, doi. 10.1002/cpt.1193
- By:
- Publication type:
- Article
HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 476, doi. 10.1002/cpt.1190
- By:
- Publication type:
- Article
Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 466, doi. 10.1002/cpt.1184
- By:
- Publication type:
- Article
Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 402, doi. 10.1002/cpt.1179
- By:
- Publication type:
- Article
CYP3A4*22 Impairs the Elimination of Ticagrelor, But Has No Significant Effect on the Bioactivation of Clopidogrel or Prasugrel.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 448, doi. 10.1002/cpt.1177
- By:
- Publication type:
- Article
Use of Lipid‐Lowering Drugs and the Risk of Cataract: A Population‐Based Nested Case‐Control Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 458, doi. 10.1002/cpt.1176
- By:
- Publication type:
- Article
Postauthorization Changes to Specific Obligations of Conditionally Authorized Medicines in the European Union: A Retrospective Cohort Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 426, doi. 10.1002/cpt.1169
- By:
- Publication type:
- Article
Assessment of Consistency of Drug Interaction Information in Drug Labels Among the United States, the United Kingdom, China, Japan, and Korea.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 505, doi. 10.1002/cpt.1167
- By:
- Publication type:
- Article
A Novel Method to Estimate Long‐Term Chronological Changes From Fragmented Observations in Disease Progression.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 436, doi. 10.1002/cpt.1166
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 269, doi. 10.1002/cpt.1151
- Publication type:
- Article
PBPK Modeling Strategy for Predicting Complex Drug Interactions of Letermovir as a Perpetrator in Support of Product Labeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 515, doi. 10.1002/cpt.1120
- By:
- Publication type:
- Article
Model‐Informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 376, doi. 10.1002/cpt.1047
- By:
- Publication type:
- Article
Challenges and Opportunities With Oncology Drug Development in China.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 2, p. 363, doi. 10.1002/cpt.1017
- By:
- Publication type:
- Article